Supply Agreements in the Biotechnology Industry

409 Contracts & Agreements

Browse by Company

89bio, Inc. (1 contract)
ACADIA PHARMACEUTICALS INC (4)
ACHIEVE LIFE SCIENCES, INC. (2)
Acorda Therapeutics (5)
Adamas Pharmaceuticals Inc (3)
Adhera Therapeutics, Inc. (2)
ADMA BIOLOGICS, INC. (2)
Advaxis, Inc. (1)
AGENUS INC (2)
Aimmune Therapeutics, Inc. (2)
Akebia Therapeutics, Inc. (13)
ALBIREO PHARMA, INC. (4)
Alexion Pharmaceuticals (1)
Alkermes plc. (6)
Alliqua BioMedical, Inc. (2)
Alpha Healthcare Acquisition Corp. (3)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (9)
Amgen Inc. (4)
AMICUS THERAPEUTICS, INC. (2)
Anika Therapeutics (1)
Apellis Pharmaceuticals, Inc. (1)
Aprea Therapeutics, Inc. (1)
Aptevo Therapeutics Inc. (1)
Aravive, Inc. (5)
Arcturus Therapeutics Holdings Inc. (1)
Arcutis Biotherapeutics, Inc. (2)
ARDELYX, INC. (2)
ARENA PHARMACEUTICALS INC (2)
Athenex, Inc. (2)
ATOSSA GENETICS INC (1)
Aurinia Pharmaceuticals Inc. (2)
BELLICUM PHARMACEUTICALS, INC (1)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BIOTIME INC (2)
BioXcel Therapeutics, Inc. (1)
bluebird bio, Inc. (6)
Bolt Biotherapeutics, Inc. (2)
Bone Biologics Corp (1)
Cabaletta Bio, Inc. (2)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
CATALYST BIOSCIENCES, INC. (2)
CATALYST PHARMACEUTICALS, INC. (1)
Celldex Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Century Therapeutics, Inc. (1)
Chelsea Worldwide Inc. (1)
ChemoCentryx, Inc. (1)
CHIMERIX INC (2)
Conatus Pharmaceuticals Inc. (1)
CTI BIOPHARMA CORP (1)
Cyclacel Pharmaceuticals, Inc. (1)
CytoDyn Inc. (11)
CYTRX CORP (1)
Deciphera Pharmaceuticals, Inc. (2)
Dermavant Sciences Ltd (2)
DiaMedica Therapeutics Inc. (1)
DYNAVAX TECHNOLOGIES CORP (12)
Eagle Pharmaceuticals, Inc. (3)
Edge Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (1)
Emergent BioSolutions Inc. (1)
Equillium, Inc. (2)
Evelo Biosciences, Inc. (1)
Exelixis (6)
FIBROGEN INC (5)
Flex Pharma, Inc. (1)
Flexion Therapeutics Inc (8)
FS Development Corp. (2)
GALECTIN THERAPEUTICS INC (1)
Gemphire Therapeutics Inc. (2)
GENEREX BIOTECHNOLOGY CORP (1)
Gilead Sciences (8)
Grail, Inc. (2)
HEMISPHERX BIOPHARMA INC (3)
HISTOGENICS CORP (3)
Homology Medicines, Inc. (1)
HUMANIGEN, INC (1)
IMMUCELL CORP (1)
IMMUNOGEN INC (1)
INSMED Inc (2)
Inspyr Therapeutics, Inc. (1)
INTERCEPT PHARMACEUTICALS, INC. (4)
IRONWOOD PHARMACEUTICALS INC (3)
Isoray, Inc. (9)
Kadmon Holdings, Inc. (2)
Kindred Biosciences, Inc. (3)
Kiniksa Pharmaceuticals, Ltd. (1)
LEXICON PHARMACEUTICALS, INC. (2)
Ligand Pharmaceuticals Incorporated (11)
MACROGENICS INC (2)
MANNKIND CORP (15)
Marker Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (1)
MEI Pharma, Inc. (1)
Minerva Neurosciences, Inc. (1)
Myovant Sciences Ltd. (5)
NantKwest, Inc. (1)
Natera, Inc. (7)
NAVIDEA BIOPHARMACEUTICALS, INC. (1)
NEUROBIOLOGICAL TECHNOLOGIES INC (1)
Neurotrope, Inc. (1)
NOVAVAX INC (5)
OncBioMune Pharmaceuticals, Inc (1)
ONCOSEC MEDICAL Inc (1)
OPGEN INC (1)
Ophthotech Corp. (1)
PALATIN TECHNOLOGIES INC (3)
PDL BIOPHARMA, INC. (2)
PhaseBio Pharmaceuticals Inc (1)
PORTOLA PHARMACEUTICALS INC (2)
Progenics Pharmaceuticals, Inc. (1)
PROGENITY, INC. (2)
Protalix BioTherapeutics, Inc. (2)
PUMA BIOTECHNOLOGY, INC. (1)
Radius Health, Inc. (6)
Regeneron Pharmaceuticals (7)
RenovoRx, Inc. (1)
Retrophin, Inc. (3)
RIGEL PHARMACEUTICALS INC (2)
RITTER PHARMACEUTICALS INC (2)
Sage Therapeutics, Inc. (3)
Sana Biotechnology, Inc. (2)
Sarepta Therapeutics, Inc. (1)
Savara Inc (4)
SEATTLE GENETICS INC (14)
Seres Therapeutics, Inc. (3)
SOLIGENIX, INC. (1)
SOPHIRIS BIO INC. (1)
Spectrum Pharmaceuticals, Inc. (9)
SPHERIX INC (1)
SYNLOGIC, INC. (1)
T2 Biosystems, Inc. (6)
TENAX THERAPEUTICS, INC. (1)
Translate Bio, Inc. (1)
TREVENA INC (1)
Twist Bioscience Corp (2)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (4)
Unicycive Therapeutics, Inc. (2)
United Therapeutics Corp (3)
UroGen Pharma Ltd. (3)
Vaxart, Inc. (1)
Vaxcyte, Inc. (2)
VBI Vaccines Inc (1)
Vericel Corp (4)
VICAL INC (5)
Viela Bio, Inc. (2)
VITRO DIAGNOSTICS INC (2)
WINDTREE THERAPEUTICS INC (2)
Xencor Inc (2)

Recent Contracts

Third Amendment to Supply Agreement, dated April 11, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc (MANNKIND CORP, Filed With SEC on November 7, 2024)
Second Amendment to Supply Agreement, dated November 9, 2016, by and between MannKind and Amphastar Pharmaceuticals, Inc (MANNKIND CORP, Filed With SEC on November 7, 2024)
Amendment #1 to Supply Agreement, dated October 15, 2024, by and between the Company and STA Pharmaceutical Hong Kong Limited (Akebia Therapeutics, Inc., Filed With SEC on November 7, 2024)
Supply Agreement with Kissei Pharmaceutical Co., Ltd., dated September 3, 2024 (RIGEL PHARMACEUTICALS INC, Filed With SEC on November 7, 2024)
Commercial Supply Agreement, dated October 25, 2024, by and among Ardelyx, Inc., Hovione Farmaciência, S.A. and Hovione, LLC (ARDELYX, INC., Filed With SEC on October 31, 2024)
Amendment No. 6 to Clinical and Commercial Supply Agreement Viral Vector Product by and between the Registrant and SAFC Carlsbad, Inc (bluebird bio, Inc., Filed With SEC on September 13, 2024)
First Amendment to Manufacturing and Supply Agreement dated June 25, 2024 by and between Unicycive Therapeutics, Inc. and Shilpa Medicare Ltd (Unicycive Therapeutics, Inc., Filed With SEC on August 14, 2024)
Manufacturing and Supply Agreement dated as of October 31, 2020 by and between Unicycive Therapeutics, Inc. and Shilpa Medicare Ltd (Unicycive Therapeutics, Inc., Filed With SEC on August 14, 2024)
Commercial Supply Agreement, dated August 7, 2024 and effective as of July 23, 2024, by and between the Company and Catalent (ARDELYX, INC., Filed With SEC on August 12, 2024)
Fourth Amendment to the Licence and Supply Agreement, dated as of June 24, 2024, between the Registrant and Oxford Biomedica (UK) Limited (Cabaletta Bio, Inc., Filed With SEC on August 8, 2024)
Amendment #2 to Supply Agreement, dated as of April 15, 2024, by and between the Company and STA Pharmaceutical Hong Kong Limited (Akebia Therapeutics, Inc., Filed With SEC on August 8, 2024)
First Amendment to the Supply and Manufacturing Services Agreement (AMICUS THERAPEUTICS, INC., Filed With SEC on August 8, 2024)
Amendment No. 1, dated July 11, 2024, to Commercial Supply Agreement, between ARx, LLC and BioXcel Therapeutics, Inc., dated April 1, 2022 (BioXcel Therapeutics, Inc., Filed With SEC on August 6, 2024)
Fourth Amendment to the Amended and Restated Supply and Commercialization Agreement, dated June 24, 2024, by and between Illumina, Inc. and GRAIL, Inc (Grail, Inc., Filed With SEC on June 24, 2024)
Supply Agreement, dated September 15, 2015, by and between the Registrant and GenIbet BioPharmaceuticals, SA, as amended (Seres Therapeutics, Inc., Filed With SEC on May 8, 2024)
Amended and Restated Exclusive Supply Agreement, dated April 25, 2024, between Clene Nanomedicine, Inc. and 4Life Research, LLC (Chelsea Worldwide Inc., Filed With SEC on April 26, 2024)
Master Services Agreement for Product Supply between Marker Therapeutics, Inc. and Cell Ready LLC dated February 22, 2024 (Marker Therapeutics, Inc., Filed With SEC on March 26, 2024)
Amendment 2 to Manufacturing & Supply Agreement, dated as of December 28, 2023 by and between UroGen Pharma Ltd. and Cenexi-Laboratoires Thissen s.a (UroGen Pharma Ltd., Filed With SEC on March 14, 2024)
Amendment No. 2 to the Manufacture and Supply Agreement, dated December 13, 2023 entered into by and between Savara ApS GEMABIOTECH SAU (Savara Inc, Filed With SEC on March 7, 2024)
Supply Agreement, dated September 15, 2015, by and between Registrant and GenIbet BioPharmaceuticals, SA, as amended (Seres Therapeutics, Inc., Filed With SEC on March 5, 2024)
Eighth Amendment to Supply Agreement, dated December 31, 2023, by and between the Registrant and Illumina, Inc (Natera, Inc., Filed With SEC on February 29, 2024)
Commercial Supply Agreement, dated March 1, 2023, by and between the Registrant and CoreRx Inc., as amended by Amendment No. 1, dated August 1, 2023 (ACADIA PHARMACEUTICALS INC, Filed With SEC on February 28, 2024)
Commercial Supply Agreement, dated December 15, 2021, by and between the Registrant and F.I.S. Fabbrica Italiana Sintetici S.p.A (ACADIA PHARMACEUTICALS INC, Filed With SEC on February 28, 2024)
Master Commercial Supply Agreement, dated November 16, 2022, by and between the Registrant and Corden Pharma Bergamo S.p.A (ACADIA PHARMACEUTICALS INC, Filed With SEC on February 28, 2024)
Commercial Manufacturing and Supply Agreement by and between the Registrant and Lonza Ltd., dated October 13, 2023 (Vaxcyte, Inc., Filed With SEC on February 27, 2024)
Commercial Supply Agreement, dated June 19, 2023, between Ultragenyx Pharmaceutical Inc. and IOI Oleo GmbH (Ultragenyx Pharmaceutical Inc., Filed With SEC on February 21, 2024)
Supply Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (VITRO DIAGNOSTICS INC, Filed With SEC on January 29, 2024)
Supply Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences (VBI Vaccines Inc, Filed With SEC on November 14, 2023)
Supply Agreement, effective as of September 7, 2023, by and between Company and Nitto Denko Avecia Inc (DYNAVAX TECHNOLOGIES CORP, Filed With SEC on November 2, 2023)
Supply Agreement, dated September 26, 2003, by and between Acorda Therapeutics, Inc. and Elan Corporation, plc (Alkermes plc., Filed With SEC on October 25, 2023)
Manufacturing and Supply Agreement - Amendment No. 2, dated May 19, 2023, by and between the Registrant and Isotopia Molecular Imaging Ltd (UroGen Pharma Ltd., Filed With SEC on August 10, 2023)
Clinical Supply Agreement, dated May 22, 2017, by and between Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018) (Equillium, Inc., Filed With SEC on August 9, 2023)
Supply and Manufacturing Services Agreement, dated as of March 31, 2023, by and among the Company, WuXi Biologics (Hong Kong) Limited, WuXi Biologics Ireland Limited and WuXi... (AMICUS THERAPEUTICS, INC., Filed With SEC on August 8, 2023)
Amendment No. 3 to Supply Agreement, by and between the Registrant and CyDex Pharmaceuticals, Inc., dated September 25, 2015 (Sage Therapeutics, Inc., Filed With SEC on August 7, 2023)
Supply Agreement by and between the Registrant and CyDex Pharmaceuticals, Inc., dated December 13, 2012, as amended August 21, 2013 and April 30, 2014 (Sage Therapeutics, Inc., Filed With SEC on August 7, 2023)
Amendment No. 3 to Supply Agreement, dated effective as of April 26, 2023, by and between Company and Biological E. Limited (DYNAVAX TECHNOLOGIES CORP, Filed With SEC on August 3, 2023)
Amendment to the Agreement for the Supply of Manufactured Products, dated May 15, 2023, between Intercept Pharma Europe Ltd. and Amdipharm Ltd (INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on May 18, 2023)
Commercial Manufacturing and Supply Agreement, dated March 14, 2023, between the Registrant and Agilent Technologies, Inc (Ophthotech Corp., Filed With SEC on May 10, 2023)
Second Amendment to Supply Agreement, dated as of January 1, 2022, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Spectrum Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)
First Amendment to Supply Agreement, dated as of December 6, 2019, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Spectrum Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)